Glioblastoma multiform (GBM) is the most common brain tumor characterized by a dismal
prognosis. GBM cancer stem cells (gCSC) or tumor-initiating cells are the cell population within …

Understanding the molecular pathways driving the acute antiviral and inflammatory response
to SARS‐CoV‐2 infection is critical for developing treatments for severe COVID‐19. Here, …

Mutations in U2AF1 are relatively common in myelodysplastic neoplasms (MDS) and are
associated with an inferior prognosis, but the molecular mechanisms underlying this are not …

Background While major advances have been made in improving the quality of life and
survival of children with most forms of medulloblastoma (MB), those with MYC-driven tumors (…

The abundance of circRNAs varies systematically between subcompartments of solid tumors
and adjacent tissues, implying that differentially expressed circRNAs discovered in bulk …

Glioblastoma is the most common malignant primary brain tumor. To date, clinically relevant
biomarkers are restricted to isocitrate dehydrogenase (IDH) gene 1 or 2 mutations and O6-…

Medulloblastoma is the most common malignant brain cancer in children. Since previous
studies have mainly focused on alterations in the coding genome, our understanding of the …

Pediatric ependymomas frequently develop in the cerebellum and are currently treated using
non‐specific therapies, in part, because few somatically mutated driver genes are present, …

Retinal gene therapy using RNA interference (RNAi) to silence targeted genes requires both
efficacy and safety. Short hairpin RNAs (shRNAs) are useful for RNAi, but high expression …

Cisplatin is a well-known cancer chemotherapeutic agent but how extensively long non-coding
RNA (lncRNA) expression is modulated by cisplatin is unknown. It is imperative to …